Atlas Trials

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Clinical trial NCT02913196 · COMPLETED

Trial details

NCT number
NCT02913196
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer Metastatic
Start date
2016-12-30
Primary completion
2021-06-30
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.